← All Sponsors
SPONSOR

Minghui Pharmaceutical (Hangzhou) Ltd

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: mCRPC (Metastatic Castration-resistant Prostate Cancer)Advanced Malignant Solid Tumor
NCT07192120 Phase 1, Phase 2
Recruiting

A Study of MHB048C in Patients With Advanced Solid Tumors

mCRPC (Metastatic Castration-resistant Prostate Cancer)
China View Trial →